BioWorld

July 22, 2010

View Archived Issues

Euthymics Acquires DOV Pharma, Gets $24M Series A

PPAR-Gamma's Good and Bad Can 'Likely' Be Disconnected

Cara Banks $15M for Pursuit of Nonaddictive Pain Drug

FDA Restricts Enrollment in GSK's Avandia Study

Other News To Note

Stock Movers

Clinic Roundup

Appointments And Advancements

Economic Headwinds Knock Gilead, Genzyme Cuts Forecast

Earnings season got off to a rocky start for the biotech sector. (BioWorld Today) Read More

23andme founder-led group outbids Regeneron for company

BioWorld

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...

Today's news in brief

BioWorld

BioWorld briefs for June 17, 2025.

Elevidys’ second liver death hits Sarepta, sends DMD ripples

BioWorld

How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 17, 2025.

3D representation of tumor microenvironment

EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment

BioWorld Science

Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...